Insider Selling: Spectral Medical Inc. (TSE:EDT) Director Sells C$97,500.00 in Stock

Spectral Medical Inc. (TSE:EDT) Director Paul M. Walker sold 150,000 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of C$0.65, for a total value of C$97,500.00.

Paul M. Walker also recently made the following trade(s):

• On Tuesday, July 16th, Paul M. Walker sold 100,000 shares of Spectral Medical stock. The shares were sold at an average price of C$0.49, for a total transaction of C$49,000.00.

Spectral Medical Stock Down 1.5 %

EDT stock opened at C$0.65 on Thursday. The company has a 50 day moving average of C$0.60 and a two-hundred day moving average of C$0.52. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03. Spectral Medical Inc. has a 12-month low of C$0.30 and a 12-month high of C$0.75. The company has a market cap of C$182.81 million, a price-to-earnings ratio of -9.43 and a beta of 0.99.

Spectral Medical (TSE:EDT) last released its quarterly earnings data on Friday, August 9th. The company reported C($0.02) earnings per share (EPS) for the quarter. The company had revenue of C$0.47 million during the quarter. On average, equities analysts anticipate that Spectral Medical Inc. will post -0.05 earnings per share for the current fiscal year.

Spectral Medical Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.